What is the current market valuation of the endoscopic retrograde-cholangiopancreatography market in Japan?

The market valuation was $85.65 Million in 2024. Read More

What is the projected market size for the endoscopic retrograde-cholangiopancreatography market by 2035?

The projected market size is $318.25 Million by 2035. Read More

Which companies are the key players in the endoscopic retrograde-cholangiopancreatography market?

Key players include Boston Scientific, Medtronic, Olympus Corporation, Cook Medical, Fujifilm Holdings Corporation, Conmed Corporation, Hoya Corporation, and B. Braun Melsungen AG. Read More

What segment had the highest valuation in the procedure category for the endoscopic retrograde-cholangiopancreatography market?

Biliary Stenting had the highest valuation at $90.0 Million. Read More

How do hospitals and clinics compare to ambulatory surgical centers in terms of market valuation?

Hospitals and clinics had a valuation of $192.0 Million, significantly higher than the $126.25 Million for ambulatory surgical centers. Read More

What is the valuation range for bile duct applications in the endoscopic retrograde-cholangiopancreatography market?

The valuation range for bile duct applications is from $34.26 Million to $130.0 Million. Read More

Which product segment is projected to have the highest growth in the endoscopic retrograde-cholangiopancreatography market?

Endoscopes are projected to have a valuation range from $20.0 Million to $75.0 Million, indicating strong growth potential. Read More

What is the valuation range for pancreatic duct stenting in the procedure segment?

The valuation range for pancreatic duct stenting is from $10.0 Million to $35.0 Million. Read More

Japan Endoscopic Retrograde Cholangiopancreatography Market

Q: What is the expected CAGR for the endoscopic retrograde-cholangiopancreatography market during the forecast period 2025 - 2035?

The expected CAGR is 12.67% during the forecast period 2025 - 2035. Read More

Q: What is the expected trend for the endoscopic retrograde-cholangiopancreatography market in Japan over the next decade?

The market is expected to grow significantly, reaching $318.25 Million by 2035, driven by a CAGR of 12.67%. Read More

Japan Endoscopic Retrograde Cholangiopancreatography Market Research Report: Size, Share, Trend Analysis By Procedure (Biliary Sphincterotomy, Biliary Stenting, Biliary Dilatation, Pancreatic Duct Stenting, Others), By End Users (Hospitals & Clinics, Ambulatory Surgical Centers), By Applications (Bile Duct, Pancreas, Others) andBy Product (Endoscopes, Imaging Devices, Energy Devices) - Growth Outlook & Industry Forecast 2025 To 2035

Forecast Period

2025 - 2035

CAGR

12.67%

2024 Market Size

$ 85.65 Million

2035 Market Size

$ 318.25 Million

Healthcare ● Updated April 2026 Report ID: MRFR/HC/49839-HCR | Pages: 200 | Author: Vikita Thakur, Garvit Vyas

Summary Table of Contents Segmentation Download PDF

SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS |
1. 1.1 EXECUTIVE SUMMARY | |
  1. 1.1.1 Market Overview | |
  2. 1.1.2 Key Findings | |
  3. 1.1.3 Market Segmentation | |
  4. 1.1.4 Competitive Landscape | |
  5. 1.1.5 Challenges and Opportunities | |
  6. 1.1.6 Future Outlook 2
SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE |
1. 2.1 MARKET INTRODUCTION | |
  1. 2.1.1 Definition | |
  2. 2.1.2 Scope of the study | | |
    1. 2.1.2.1 Research Objective | | |
    2. 2.1.2.2 Assumption | | |
    3. 2.1.2.3 Limitations |
2. 2.2 RESEARCH METHODOLOGY | |
  1. 2.2.1 Overview | |
  2. 2.2.2 Data Mining | |
  3. 2.2.3 Secondary Research | |
  4. 2.2.4 Primary Research | | |
    1. 2.2.4.1 Primary Interviews and Information Gathering Process | | |
    2. 2.2.4.2 Breakdown of Primary Respondents | |
  5. 2.2.5 Forecasting Model | |
  6. 2.2.6 Market Size Estimation | | |
    1. 2.2.6.1 Bottom-Up Approach | | |
    2. 2.2.6.2 Top-Down Approach | |
  7. 2.2.7 Data Triangulation | |
  8. 2.2.8 Validation 3
SECTION III: QUALITATIVE ANALYSIS |
1. 3.1 MARKET DYNAMICS | |
  1. 3.1.1 Overview | |
  2. 3.1.2 Drivers | |
  3. 3.1.3 Restraints | |
  4. 3.1.4 Opportunities |
2. 3.2 MARKET FACTOR ANALYSIS | |
  1. 3.2.1 Value chain Analysis | |
  2. 3.2.2 Porter's Five Forces Analysis | | |
    1. 3.2.2.1 Bargaining Power of Suppliers | | |
    2. 3.2.2.2 Bargaining Power of Buyers | | |
    3. 3.2.2.3 Threat of New Entrants | | |
    4. 3.2.2.4 Threat of Substitutes | | |
    5. 3.2.2.5 Intensity of Rivalry | |
  3. 3.2.3 COVID-19 Impact Analysis | | |
    1. 3.2.3.1 Market Impact Analysis | | |
    2. 3.2.3.2 Regional Impact | | |
    3. 3.2.3.3 Opportunity and Threat Analysis 4
SECTION IV: QUANTITATIVE ANALYSIS |
1. 4.1 Life Sciences, BY Procedure (USD Million) | |
  1. 4.1.1 Biliary Sphincterotomy | |
  2. 4.1.2 Biliary Stenting | |
  3. 4.1.3 Biliary Dilatation | |
  4. 4.1.4 Pancreatic Duct Stenting | |
  5. 4.1.5 Others |
2. 4.2 Life Sciences, BY End User (USD Million) | |
  1. 4.2.1 Hospitals & Clinics | |
  2. 4.2.2 Ambulatory Surgical Centers |
3. 4.3 Life Sciences, BY Application (USD Million) | |
  1. 4.3.1 Bile Duct | |
  2. 4.3.2 Pancreas | |
  3. 4.3.3 Others |
4. 4.4 Life Sciences, BY Product (USD Million) | |
  1. 4.4.1 Endoscopes | |
  2. 4.4.2 Endotherapy Devices | |
  3. 4.4.3 Catheters | |
  4. 4.4.4 Stents | |
  5. 4.4.5 Balloons | |
  6. 4.4.6 Guiding Wires | |
  7. 4.4.7 Others | |
  8. 4.4.8 Imaging Devices | |
  9. 4.4.9 Energy Devices 5
SECTION V: COMPETITIVE ANALYSIS |
1. 5.1 Competitive Landscape | |
  1. 5.1.1 Overview | |
  2. 5.1.2 Competitive Analysis | |
  3. 5.1.3 Market share Analysis | |
  4. 5.1.4 Major Growth Strategy in the Life Sciences | |
  5. 5.1.5 Competitive Benchmarking | |
  6. 5.1.6 Leading Players in Terms of Number of Developments in the Life Sciences | |
  7. 5.1.7 Key developments and growth strategies | | |
    1. 5.1.7.1 New Product Launch/Service Deployment | | |
    2. 5.1.7.2 Merger & Acquisitions | | |
    3. 5.1.7.3 Joint Ventures | |
  8. 5.1.8 Major Players Financial Matrix | | |
    1. 5.1.8.1 Sales and Operating Income | | |
    2. 5.1.8.2 Major Players R&D Expenditure. 2023 |
2. 5.2 Company Profiles | |
  1. 5.2.1 Boston Scientific (US) | | |
    1. 5.2.1.1 Financial Overview | | |
    2. 5.2.1.2 Products Offered | | |
    3. 5.2.1.3 Key Developments | | |
    4. 5.2.1.4 SWOT Analysis | | |
    5. 5.2.1.5 Key Strategies | |
  2. 5.2.2 Medtronic (US) | | |
    1. 5.2.2.1 Financial Overview | | |
    2. 5.2.2.2 Products Offered | | |
    3. 5.2.2.3 Key Developments | | |
    4. 5.2.2.4 SWOT Analysis | | |
    5. 5.2.2.5 Key Strategies | |
  3. 5.2.3 Olympus Corporation (JP) | | |
    1. 5.2.3.1 Financial Overview | | |
    2. 5.2.3.2 Products Offered | | |
    3. 5.2.3.3 Key Developments | | |
    4. 5.2.3.4 SWOT Analysis | | |
    5. 5.2.3.5 Key Strategies | |
  4. 5.2.4 Cook Medical (US) | | |
    1. 5.2.4.1 Financial Overview | | |
    2. 5.2.4.2 Products Offered | | |
    3. 5.2.4.3 Key Developments | | |
    4. 5.2.4.4 SWOT Analysis | | |
    5. 5.2.4.5 Key Strategies | |
  5. 5.2.5 Fujifilm Holdings Corporation (JP) | | |
    1. 5.2.5.1 Financial Overview | | |
    2. 5.2.5.2 Products Offered | | |
    3. 5.2.5.3 Key Developments | | |
    4. 5.2.5.4 SWOT Analysis | | |
    5. 5.2.5.5 Key Strategies | |
  6. 5.2.6 Conmed Corporation (US) | | |
    1. 5.2.6.1 Financial Overview | | |
    2. 5.2.6.2 Products Offered | | |
    3. 5.2.6.3 Key Developments | | |
    4. 5.2.6.4 SWOT Analysis | | |
    5. 5.2.6.5 Key Strategies | |
  7. 5.2.7 Hoya Corporation (JP) | | |
    1. 5.2.7.1 Financial Overview | | |
    2. 5.2.7.2 Products Offered | | |
    3. 5.2.7.3 Key Developments | | |
    4. 5.2.7.4 SWOT Analysis | | |
    5. 5.2.7.5 Key Strategies | |
  8. 5.2.8 B. Braun Melsungen AG (DE) | | |
    1. 5.2.8.1 Financial Overview | | |
    2. 5.2.8.2 Products Offered | | |
    3. 5.2.8.3 Key Developments | | |
    4. 5.2.8.4 SWOT Analysis | | |
    5. 5.2.8.5 Key Strategies |
3. 5.3 Appendix | |
  1. 5.3.1 References | |
  2. 5.3.2 Related Reports 6 LIST OF FIGURES |
4. 6.1 MARKET SYNOPSIS |
5. 6.2 JAPAN MARKET ANALYSIS BY PROCEDURE |
6. 6.3 JAPAN MARKET ANALYSIS BY END USER |
7. 6.4 JAPAN MARKET ANALYSIS BY APPLICATION |
8. 6.5 JAPAN MARKET ANALYSIS BY PRODUCT |
9. 6.6 KEY BUYING CRITERIA OF LIFE SCIENCES |
10. 6.7 RESEARCH PROCESS OF MRFR |
11. 6.8 DRO ANALYSIS OF LIFE SCIENCES |
12. 6.9 DRIVERS IMPACT ANALYSIS: LIFE SCIENCES |
13. 6.10 RESTRAINTS IMPACT ANALYSIS: LIFE SCIENCES |
14. 6.11 SUPPLY / VALUE CHAIN: LIFE SCIENCES |
15. 6.12 LIFE SCIENCES, BY PROCEDURE, 2024 (% SHARE) |
16. 6.13 LIFE SCIENCES, BY PROCEDURE, 2024 TO 2035 (USD Million) |
17. 6.14 LIFE SCIENCES, BY END USER, 2024 (% SHARE) |
18. 6.15 LIFE SCIENCES, BY END USER, 2024 TO 2035 (USD Million) |
19. 6.16 LIFE SCIENCES, BY APPLICATION, 2024 (% SHARE) |
20. 6.17 LIFE SCIENCES, BY APPLICATION, 2024 TO 2035 (USD Million) |
21. 6.18 LIFE SCIENCES, BY PRODUCT, 2024 (% SHARE) |
22. 6.19 LIFE SCIENCES, BY PRODUCT, 2024 TO 2035 (USD Million) |
23. 6.20 BENCHMARKING OF MAJOR COMPETITORS 7 LIST OF TABLES |
24. 7.1 LIST OF ASSUMPTIONS | |
  1. 7.1.1 |
25. 7.2 Japan MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.2.1 BY PROCEDURE, 2025-2035 (USD Million) | |
  2. 7.2.2 BY END USER, 2025-2035 (USD Million) | |
  3. 7.2.3 BY APPLICATION, 2025-2035 (USD Million) | |
  4. 7.2.4 BY PRODUCT, 2025-2035 (USD Million) |
26. 7.3 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL | |
  1. 7.3.1 |
27. 7.4 ACQUISITION/PARTNERSHIP | |

Certified Researchers

Customize Report

Japan Endoscopic Retrograde Cholangiopancreatography Market Segmentation

Japan Endoscopic Retrograde Cholangiopancreatography Market By Procedure (USD Million, 2025-2035)

Biliary Sphincterotomy
Biliary Stenting
Biliary Dilatation
Pancreatic Duct Stenting
Others

Japan Endoscopic Retrograde Cholangiopancreatography Market By End User (USD Million, 2025-2035)

Hospitals & Clinics
Ambulatory Surgical Centers

Japan Endoscopic Retrograde Cholangiopancreatography Market By Application (USD Million, 2025-2035)

Bile Duct
Pancreas
Others

Japan Endoscopic Retrograde Cholangiopancreatography Market By Product (USD Million, 2025-2035)

Endoscopes
Endotherapy Devices
Catheters
Stents
Balloons
Guiding Wires
Others
Imaging Devices
Energy Devices

Certified Researchers

Customize Report

Customer Stories

“This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job”

Noah Malgeri Co-Founder

“Thanks. It’s been a pleasure working with you, please use me as reference with any other Intel employees.”

Joseph Aguayo Sales Operations & Pricing Manager

“Thanks for sending the report it gives us a good global view of the Betaïne market.”

Peter Groot koerkamp Account and Business Manager

“Thank you, this will be very helpful for OQS.”

La Terria Dodd Program Support Specialist

“We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.”

Younghwan Choi Senior Retail Manager

“I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

Mark Irwin Management Consultant

“I have been reading the first document or the study, ,the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!”

Rob Kooiker Group Product Manager HVAC & Fire Protection GMA

“We got the report in time, we really thank you for your support in this process. I also thank to all of your team as they did a great job.”

Akif Moroglu Strategy & Business Development Director

“The Automotive 48V ECU Components Procurement Intelligence Study” was a complex project, but the Market Research Future (MRFR) team handled it with quality, agility, and customer-centricity. They delivered all requested data on time and within the agreed scope. The team, including Shubhendra Anand and Rahul Gotadki, was always readily available to clarify questions and swiftly implement necessary adjustments, driving the project to a successful conclusion within a very demanding timeframe.
I would also like to specifically commend Akshay Agarwal for his responsiveness and support at every stage—from our initial inquiry on May 6th through to final delivery on June 18th. His dedication made the entire process seamless.”

Guilherme Gomes Martins Product Management Director

Case Study

Aerospace & Defense

Future of Dismounted Soldier Systems Market Trends & Adoption Roadmap 2019–2035